PT74520B - Verfahren zur herstellung neuer pyridazinona und pharmazeutis- che praeparate enthaltend diese verbindungen und deren verwendung - Google Patents
Verfahren zur herstellung neuer pyridazinona und pharmazeutis- che praeparate enthaltend diese verbindungen und deren verwendungInfo
- Publication number
- PT74520B PT74520B PT74520A PT7452082A PT74520B PT 74520 B PT74520 B PT 74520B PT 74520 A PT74520 A PT 74520A PT 7452082 A PT7452082 A PT 7452082A PT 74520 B PT74520 B PT 74520B
- Authority
- PT
- Portugal
- Prior art keywords
- pyridazinona
- contained
- preparing new
- preparates
- pharmaceutical
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- -1 amino, acetylamino, methyl Chemical group 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 229910052740 iodine Chemical group 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treating Waste Gases (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH144381 | 1981-03-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT74520A PT74520A (de) | 1982-04-01 |
| PT74520B true PT74520B (de) | 1984-11-19 |
Family
ID=4210578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT74520A PT74520B (de) | 1981-03-04 | 1982-03-03 | Verfahren zur herstellung neuer pyridazinona und pharmazeutis- che praeparate enthaltend diese verbindungen und deren verwendung |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US4613599A (pt) |
| EP (1) | EP0059688B1 (pt) |
| JP (1) | JPS57158762A (pt) |
| AT (1) | ATE13294T1 (pt) |
| AU (1) | AU558039B2 (pt) |
| CA (1) | CA1180703A (pt) |
| CY (1) | CY1396A (pt) |
| DD (1) | DD209461A5 (pt) |
| DE (1) | DE3263497D1 (pt) |
| DK (1) | DK148772C (pt) |
| ES (4) | ES510055A0 (pt) |
| FI (1) | FI72718C (pt) |
| GB (1) | GB2094302B (pt) |
| GR (1) | GR81397B (pt) |
| HK (1) | HK87687A (pt) |
| HU (1) | HU191083B (pt) |
| IE (1) | IE52672B1 (pt) |
| IL (1) | IL65161A (pt) |
| MY (1) | MY8700736A (pt) |
| NO (1) | NO158135C (pt) |
| NZ (1) | NZ199892A (pt) |
| PT (1) | PT74520B (pt) |
| SG (1) | SG59587G (pt) |
| ZA (1) | ZA821397B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734415A (en) * | 1982-08-13 | 1988-03-29 | Warner-Lambert Company | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones |
| GB8400863D0 (en) * | 1984-01-13 | 1984-02-15 | Smith Kline French Lab | Chemical compounds |
| GB8426804D0 (en) * | 1984-10-23 | 1984-11-28 | Ciba Geigy Ag | Pyridazinones preparations |
| JPS61158969A (ja) * | 1984-12-24 | 1986-07-18 | ワーナー‐ランバート・コンパニー | ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類 |
| IL79280A (en) * | 1985-07-05 | 1990-07-12 | Smith Kline French Lab | 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them |
| US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
| DE3735207A1 (de) * | 1987-10-17 | 1989-04-27 | Basf Ag | Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren |
| EP2970145B1 (en) * | 2013-03-11 | 2020-05-06 | The Broad Institute, Inc. | Compounds and compositions for the treatment of cancer |
| JOP20200024A1 (ar) | 2017-08-04 | 2020-02-02 | Bayer Ag | مركبات ثنائي هيدروكساديازينون |
| US11897867B2 (en) | 2017-08-04 | 2024-02-13 | Bayer Aktiengesellschaft | 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1488330A (en) * | 1923-02-01 | 1924-03-25 | Everitt James | Clothes-hanging bar formed of hinged-together members |
| IL37788A0 (en) * | 1970-10-09 | 1971-12-29 | American Cyanamid Co | New pyridazinone compounds,their preparation and pharmaceutical compositions containing them |
| US3975388A (en) * | 1971-02-22 | 1976-08-17 | Bdh Pharmaceuticals Limited | Pyridazinones |
| GB1383906A (en) * | 1971-02-22 | 1974-02-12 | Bdh Pharmaceuticals Ltd | Pyridazinones |
| GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
| DE2854191A1 (de) * | 1978-12-15 | 1980-07-03 | Basf Ag | Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel |
-
1982
- 1982-02-26 AT AT82810090T patent/ATE13294T1/de active
- 1982-02-26 EP EP82810090A patent/EP0059688B1/de not_active Expired
- 1982-02-26 DE DE8282810090T patent/DE3263497D1/de not_active Expired
- 1982-02-26 FI FI820699A patent/FI72718C/fi not_active IP Right Cessation
- 1982-03-02 GR GR67459A patent/GR81397B/el unknown
- 1982-03-02 GB GB8205989A patent/GB2094302B/en not_active Expired
- 1982-03-02 CY CY139682A patent/CY1396A/xx unknown
- 1982-03-02 ES ES510055A patent/ES510055A0/es active Granted
- 1982-03-02 CA CA000397433A patent/CA1180703A/en not_active Expired
- 1982-03-03 AU AU81065/82A patent/AU558039B2/en not_active Ceased
- 1982-03-03 IE IE478/82A patent/IE52672B1/en unknown
- 1982-03-03 NO NO820670A patent/NO158135C/no unknown
- 1982-03-03 ZA ZA821397A patent/ZA821397B/xx unknown
- 1982-03-03 DD DD82237856A patent/DD209461A5/de unknown
- 1982-03-03 IL IL65161A patent/IL65161A/xx unknown
- 1982-03-03 PT PT74520A patent/PT74520B/pt unknown
- 1982-03-03 DK DK91782A patent/DK148772C/da not_active IP Right Cessation
- 1982-03-03 HU HU82652A patent/HU191083B/hu unknown
- 1982-03-03 NZ NZ199892A patent/NZ199892A/en unknown
- 1982-03-04 JP JP57033169A patent/JPS57158762A/ja active Pending
-
1983
- 1983-02-23 ES ES520023A patent/ES520023A0/es active Granted
- 1983-02-23 ES ES520022A patent/ES520022A0/es active Granted
- 1983-02-23 ES ES520024A patent/ES8403894A1/es not_active Expired
-
1985
- 1985-07-24 US US06/758,833 patent/US4613599A/en not_active Expired - Fee Related
-
1986
- 1986-05-05 US US06/859,684 patent/US4654340A/en not_active Expired - Fee Related
- 1986-11-28 US US06/935,901 patent/US4704391A/en not_active Expired - Fee Related
-
1987
- 1987-07-22 SG SG595/87A patent/SG59587G/en unknown
- 1987-11-26 HK HK876/87A patent/HK87687A/xx unknown
- 1987-12-30 MY MY736/87A patent/MY8700736A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE5967T1 (de) | 3,4-diarylisoxazol-5-essigsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel. | |
| PT74520B (de) | Verfahren zur herstellung neuer pyridazinona und pharmazeutis- che praeparate enthaltend diese verbindungen und deren verwendung | |
| ATE38988T1 (de) | Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| DE3773026D1 (de) | Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung, sowie diese verbindungen enthaltende arzneimittel. | |
| PT83309A (de) | Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel | |
| PT78545B (pt) | Verfahren zur herstellung cephemverbindungen | |
| ATE11133T1 (de) | Pyridincarbinole, verfahren zu ihrer herstellung und diese enthaltende fungizide. | |
| PT78062A (fr) | Procede pour preparer de nouveaux derives de betaines n-iminopyridinium et de compositions pharmaceutiques les contenant | |
| ES8304122A1 (es) | "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos". | |
| ATE9330T1 (de) | Phenethanolamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE39114T1 (de) | Substituierte pyridazinone, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen und deren verwendung. | |
| ATE121724T1 (de) | Neue salze der 2-(2,6-dichloranilino)- phenylessigsäure, verfahren zu ihrer herstellung und ihre verwendung für topisch anwendbare pharmazeutische zubereitungen. | |
| ATE33837T1 (de) | Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE11530T1 (de) | P-chlorophenoxyessigsaeure-derivat, verfahren zu dessen herstellung und pharmazeutische zusammenstellung. | |
| ATA173677A (de) | Verfahren zur herstellung von beta,beta'-thiodipropionsaeurediamid |